content: Total Number of Pages:  5
  Exhibit Index on Sequential Page No.:  3
  
  
  SECURITIES AND EXCHANGE COMMISSION
  
  Washington, D.C.  20549
  
  
  FORM 8-K
  
  CURRENT REPORT
  
  
  Pursuant to Section 13 or 15(d) of
  the Securities Exchange Act of 1934
  
  
  Date of Report (Date of earliest event reported):    November 6, 1995   
  
  
                    ORNDA HEALTHCORP                
  (Exact name of registrant as specified in its charter)
  
  
                        DELAWARE                         
  (State or other jurisdiction of incorporation)
  
  
          0-11290                            75-1776092
  (Commission File Number)        (IRS Employer Identification No.)
  
  3401 West End Avenue, Nashville, Tennessee      37203      
  (Address of principal executive office)       (Zip Code)
  
  Registrant's telephone number, including area code:  (615) 383-8599<PAGE>
  
  Item 5.   Other Events.
  
            The Registrant hereby incorporates by reference the description of
  the matter set forth in its news release dated November 6, 1995 (such news
  release being Exhibit 99 attached hereto).
  
  Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.
  
            (c)  Exhibits.
  
            99   Registrant's news release dated November 6, 1995.
  
  
  SIGNATURES
  
            Pursuant to the requirements of the Securities Exchange Act of 1934,
  the Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
  ORNDA HEALTHCORP
  
  (Signature)
  Ronald P. Soltman
  Senior Vice President
  
  Date:  November 8, 1995<PAGE>
  
  EXHIBIT INDEX
  
                                                                                 
                                                                      Sequential
  No.      Subject Matter                                               Page No.
  
  99        Registrant's new release dated November 6, 1995.. . . . . . . . .4<PAGE>
                                                                    Exhibit 99<PAGE>
  FOR IMMEDIATE RELEASE
  
  Contact:     Keith B. Pitts
               Executive Vice President and Chief Financial Officer
               or
               Tripp Pilgrim
               Director of Investor Relations
               OrNda HealthCorp
               (615) 383-8599
  
            ORNDA COMPLETES THE PUBLIC OFFERING OF ITS COMMON STOCK
  
            NASHVILLE, Tennessee (November 6, 1995) - OrNda HealthCorp (Nasdaq
  NM: ORND) announced completion of a public offering of 10 million shares of
  its Common Stock at a $17.625 per share public offering price.  All of the
  shares were sold by OrNda.
  
            Merrill Lynch & Co. and its international affiliate were the lead
  managers of both the offering in the United States and Canada of  8 million
  shares and the concurrent international offering of 2 million shares, with
  Donaldson, Lufkin & Jenrette Securities Corporation, Smith Barney Inc. and
  Johnson Rice & Company L.L.C. acting as co-managers for both offerings. 
  OrNda has granted the underwriters an option for 30 days to purchase up to an
  additional 1.5 million shares solely to cover over-allotments.
  
             OrNda received approximately $168 million  in aggregate net
  proceeds from these offerings.  OrNda intends to use the net proceeds from
  these offerings (as well as the proceeds from any exercise of the
  over-allotment option) to reduce existing bank indebtedness and for
  general corporate purposes, including strategic acquisitions.
  
            OrNda HealthCorp is the third largest investor-owned hospital
  management company in the United States.  It is a leading provider of health
  care services, delivering a broad range of inpatient and outpatient health
  care services principally through the operation of 47 hospitals located in
  urban and suburban communities in 14 states.
  
                                      # # #
metadata_documents: [{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 3787}]
metadata_filer: {"company-data": {"conformed-name": "ORNDA HEALTHCORP", "cik": "0000719242", "assigned-sic": "8060", "irs-number": "751776092", "state-of-incorporation": "DE", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-11290", "film-number": "95588042"}, "business-address": {"street1": "3401 W END AVE STE 700", "city": "NASHVILLE", "state": "TN", "zip": "37203-1042", "phone": "6153838599"}, "mail-address": {"street1": "3401 WEST END AVE", "street2": "SUITE 700", "city": "NASHVILLE", "state": "TN", "zip": "37203-1042"}, "former-company": {"former-conformed-name": "REPUBLIC HEALTH CORP", "date-changed": "19920415"}}
text: Total Number of Pages:  5
  Exhibit Index on Sequential Page No.:  3
  
  SECURITIES AND EXCHANGE COMMISSION
  
  Washington, D.C.  20549
  
  FORM 8-K
  
  CURRENT REPORT
  
  Pursuant to Section 13 or 15(d) of
  the Securities Exchange Act of 1934
  
  Date of Report (Date of earliest event reported):    November 6, 1995   
  
                    ORNDA HEALTHCORP                
  (Exact name of registrant as specified in its charter)
  
                        DELAWARE                         
  (State or other jurisdiction of incorporation)
  
          0-11290                            75-1776092
  (Commission File Number)        (IRS Employer Identification No.)
  
  3401 West End Avenue, Nashville, Tennessee      37203      
  (Address of principal executive office)       (Zip Code)
  
  Registrant's telephone number, including area code:  (615) 383-8599
  Item 5.   Other Events.
  
            The Registrant hereby incorporates by reference the description of
  the matter set forth in its news release dated November 6, 1995 (such news
  release being Exhibit 99 attached hereto).
  
  Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.
  
            (c)  Exhibits.
  
            99   Registrant's news release dated November 6, 1995.
  
  SIGNATURES
  
            Pursuant to the requirements of the Securities Exchange Act of 1934,
  the Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
  ORNDA HEALTHCORP
  
  (Signature)
  Ronald P. Soltman
  Senior Vice President
  
  Date:  November 8, 1995
  EXHIBIT INDEX
  
                                                                                 
                                                                      Sequential
  No.      Subject Matter                                               Page No.
  
  99        Registrant's new release dated November 6, 1995.. . . . . . . . .4
  Exhibit 99
  FOR IMMEDIATE RELEASE
  
  Contact:     Keith B. Pitts
               Executive Vice President and Chief Financial Officer
               or
               Tripp Pilgrim
               Director of Investor Relations
               OrNda HealthCorp
               (615) 383-8599
  
            ORNDA COMPLETES THE PUBLIC OFFERING OF ITS COMMON STOCK
  
            NASHVILLE, Tennessee (November 6, 1995) - OrNda HealthCorp (Nasdaq
  NM: ORND) announced completion of a public offering of 10 million shares of
  its Common Stock at a $17.625 per share public offering price.  All of the
  shares were sold by OrNda.
  
            Merrill Lynch & Co. and its international affiliate were the lead
  managers of both the offering in the United States and Canada of  8 million
  shares and the concurrent international offering of 2 million shares, with
  Donaldson, Lufkin & Jenrette Securities Corporation, Smith Barney Inc. and
  Johnson Rice & Company L.L.C. acting as co-managers for both offerings. 
  OrNda has granted the underwriters an option for 30 days to purchase up to an
  additional 1.5 million shares solely to cover over-allotments.
  
             OrNda received approximately $168 million  in aggregate net
  proceeds from these offerings.  OrNda intends to use the net proceeds from
  these offerings (as well as the proceeds from any exercise of the
  over-allotment option) to reduce existing bank indebtedness and for
  general corporate purposes, including strategic acquisitions.
  
            OrNda HealthCorp is the third largest investor-owned hospital
  management company in the United States.  It is a leading provider of health
  care services, delivering a broad range of inpatient and outpatient health
  care services principally through the operation of 47 hospitals located in
  urban and suburban communities in 14 states.
  
                                      # # #